Chih-hung J. Lee

129, Sec. 3, Sanmin Road
Taitung, TNQ 40401, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 129 publications

Amlitelimab, an anti-OX40 ligand antibody, for atopic dermatitis: a plain language summary of STREAM-AD clinical study.

Amlitelimab, an anti-OX40 ligand antibody, for atopic dermatitis: a plain language summary of STREAM-AD clinical study.

Journal: Immunotherapy

Published: September 01, 2025

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of OBI-858 for the Treatment of Moderate-to-Severe Glabellar Lines.

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of OBI-858 for the Treatment of Moderate-to-Severe Glabellar Lines.

Journal: Dermatology and therapy

Published: August 29, 2025

Building the foundations for an international patient-centred outcomes set for psoriasis: A scoping study.

Building the foundations for an international patient-centred outcomes set for psoriasis: A scoping study.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: June 30, 2025

Extracorporeal shockwave therapy ameliorates skin inflammation of imiquimod-induced psoriasis in mice.

Extracorporeal shockwave therapy ameliorates skin inflammation of imiquimod-induced psoriasis in mice.

Journal: Biomedical journal

Published: June 08, 2025

Increased morbidities in pyoderma gangrenosum with extensive surgical debridement in Taiwan: a case series.

Increased morbidities in pyoderma gangrenosum with extensive surgical debridement in Taiwan: a case series.

Journal: Journal of wound care

Published: May 13, 2025

Population Pharmacokinetic and Pharmacodynamic Modeling for the Prediction of the Extended Amlitelimab Phase 3 Dosing Regimen in Atopic Dermatitis.

Population Pharmacokinetic and Pharmacodynamic Modeling for the Prediction of the Extended Amlitelimab Phase 3 Dosing Regimen in Atopic Dermatitis.

Journal: CPT: pharmacometrics & systems pharmacology

Published: April 24, 2025

Incidence of skin cancer versus overall de novo malignancies among living donor liver transplantation recipients in Taiwan: a cohort study.

Incidence of skin cancer versus overall de novo malignancies among living donor liver transplantation recipients in Taiwan: a cohort study.

Journal: The British journal of dermatology

Published: March 13, 2025

Endothelin-1 Participates in the Pathogenesis of Prurigo Nodularis by Promoting NGF Expression via Endothelial Receptor B in Epidermal Keratinocytes and Dorsal Root Ganglion Cells.

Endothelin-1 Participates in the Pathogenesis of Prurigo Nodularis by Promoting NGF Expression via Endothelial Receptor B in Epidermal Keratinocytes and Dorsal Root Ganglion Cells.

Journal: Allergy

Published: March 03, 2025

Sequential rechallenge of anti-tuberculosis drugs of isoniazid-induced linear IgA dermatosis mimicking toxic epidermal necrolysis.

Sequential rechallenge of anti-tuberculosis drugs of isoniazid-induced linear IgA dermatosis mimicking toxic epidermal necrolysis.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Published: October 12, 2024

Rapid and noninvasive estimation of human arsenic exposure based on 4-photo-set of the hand and foot photos through artificial intelligence.

Rapid and noninvasive estimation of human arsenic exposure based on 4-photo-set of the hand and foot photos through artificial intelligence.

Journal: Journal of hazardous materials

Published: August 28, 2024

Phase 2b randomized clinical trial of amlitelimab, an anti-OX40 ligand antibody, in patients with moderate-to-severe atopic dermatitis.

Phase 2b randomized clinical trial of amlitelimab, an anti-OX40 ligand antibody, in patients with moderate-to-severe atopic dermatitis.

Journal: The Journal of allergy and clinical immunology

Published: July 26, 2024

Deep Deblurring in Teledermatology: Deep Learning Models Restore the Accuracy of Blurry Images' Classification.

Deep Deblurring in Teledermatology: Deep Learning Models Restore the Accuracy of Blurry Images' Classification.

Journal: Telemedicine journal and e-health : the official journal of the American Telemedicine Association

Published: June 27, 2024

Showing 1-12 of 129

Last Updated: 09/26/2026